拉米夫定治疗慢性乙型肝炎研究进展

被引：7

作者：

肖绍树 ^{[1
]}

周翔 ^{[2
]}

机构：

[1] 湖北省黄石市第五医院消化内科

[2] 黄石市第五医院消化外科

来源：

中华实验和临床感染病杂志(电子版) | 2009年 / 3卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R512.62 [];

学科分类号：

摘要：

引用

页码：324 / 328

页数：5

共 13 条

[1]

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial.[J].Harry LA Janssen;Monika van Zonneveld;Hakan Senturk;Stefan Zeuzem;Ulus S Akarca;Yilmaz Cakaloglu;Christopher Simon;Thomas MK So;Guido Gerken;Robert A de Man;Hubert GM Niesters;Pieter Zondervan;Bettina Hansen;Solko W Schalm.The Lancet.2005, 9454

[2]

Successful pregnancy in a liver transplant recipient treated with lamivudine for de novo hepatitis B in the graft.[J].Massimiliano Loreno;Patrizio Bo;Marco Senzolo;Umberto Cillo;Nikolai Naoumov;Patrizia Burra.Transplant International.2005, 11

[3]

Maternal-fetal transfer and amniotic fluid accumulation of lamivudine in human immunodeficiency virus–infected pregnant women.[J].Laurent Mandelbrot;Gilles Peytavin;Ghislaine Firtion;Robert Farinotti.American Journal of Obstetrics and Gynecology.2001, 2

[4]

Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy [J].